Malignant Uterine Neoplasm Completed Phase 0 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0086739 (Malignant Uterine Neoplasm)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02646319Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsTreatment